Resultados da busca - Fraser Cummings

Refinar Resultados
  1. 1
    JAK1 inhibition and inflammatory bowel disease

    JAK1 inhibition and inflammatory bowel disease por Clare Harris, Fraser Cummings

    Publicado em 2020
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  2. 2
    Medical management of Crohn’s disease

    Medical management of Crohn’s disease por Fraser Cummings, Satish Keshav, Simon Travis

    Publicado em 2008
    Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  3. 3
    Adalimumab Biosimilars in Europe: An Overview of the Clinical Evidence

    Adalimumab Biosimilars in Europe: An Overview of the Clinical Evidence por Salvatore Bellinvia, Fraser Cummings, Michael R. Ardern‐Jones, Christopher J Edwards

    Publicado em 2019
    Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  4. 4
    Life in lockdown: experiences of patients with IBD during COVID-19

    Life in lockdown: experiences of patients with IBD during COVID-19 por Richard Harris, Louise Downey, Trevor Smith, Fraser Cummings, Richard Felwick, Markus Gwiggner

    Publicado em 2020
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  5. 5
    Oral methotrexate in ulcerative colitis

    Oral methotrexate in ulcerative colitis por Fraser Cummings, Klaus R. Herrlinger, Simon Travis, Stephen Gorard, A. S. McIntyre, D P Jewell

    Publicado em 2005
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  6. 6
    Human Intestinal Macrophages Are Involved in the Pathology of Both Ulcerative Colitis and Crohn Disease

    Human Intestinal Macrophages Are Involved in the Pathology of Both Ulcerative Colitis and Crohn Disease por Suranga Dharmasiri, Eva M. Garrido-Martín, Richard Harris, Adrian C Bateman, Jane Collins, Fraser Cummings, Tilman Sanchez‐Elsner

    Publicado em 2021
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  7. 7
    QT and QTc dispersion are accurate predictors of cardiac death in newly diagnosed non-insulin dependent diabetes: cohort study

    QT and QTc dispersion are accurate predictors of cardiac death in newly diagnosed non-insulin dependent diabetes: cohort study por A. A O Naas, Neil C. Davidson, C. Thompson, Fraser Cummings, S. Ogston, R. T. Jung, Richard Newton, Allan D. Struthers

    Publicado em 1998
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  8. 8
    MicroRNA-31 and MicroRNA-155 Are Overexpressed in Ulcerative Colitis and Regulate IL-13 Signaling by Targeting Interleukin 13 Receptor α-1

    MicroRNA-31 and MicroRNA-155 Are Overexpressed in Ulcerative Colitis and Regulate IL-13 Signaling by Targeting Interleukin 13 Receptor α-1 por Markus Gwiggner, Rocío T. Martínez-Nuñez, Simon Whiteoak, Victor P. Bondanese, A Claridge, Jane Collins, Fraser Cummings, Tilman Sanchez‐Elsner

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  9. 9
    Th17 Cells Expressing KIR3DL2+ and Responsive to HLA-B27 Homodimers Are Increased in Ankylosing Spondylitis

    Th17 Cells Expressing KIR3DL2+ and Responsive to HLA-B27 Homodimers Are Increased in Ankylosing Spondylitis por Paul Bowness, Anna Ridley, Jacqueline Shaw, Antoni Chan, Isabel Wong‐Baeza, Myles Fleming, Fraser Cummings, Andrew J. McMichael, Simon Kollnberger

    Publicado em 2011
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  10. 10
    Contribution of the novel inflammatory bowel disease gene IL23R to disease susceptibility and phenotype

    Contribution of the novel inflammatory bowel disease gene IL23R to disease susceptibility and phenotype por Fraser Cummings, Tariq Ahmad, Alessandra Geremia, John Beckly, Rachel Cooney, Laura Hancock, Saad Pathan, Changcun Guo, Lon R. Cardon, Derek P. Jewell

    Publicado em 2007
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  11. 11
    Transitioning from Intravenous to Subcutaneous Vedolizumab in Patients with Inflammatory Bowel Disease [TRAVELESS]

    Transitioning from Intravenous to Subcutaneous Vedolizumab in Patients with Inflammatory Bowel Disease [TRAVELESS] por Esther Ventress, David Young, Sohail Rahmany, Clare Harris, Marion Bettey, Trevor Smith, Helen Moyses, Magdalena Lech, Markus Gwiggner, Richard Felwick, Fraser Cummings

    Publicado em 2021
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  12. 12
    The pattern and outcome of acute severe colitis

    The pattern and outcome of acute severe colitis por Lotte C. Dinesen, Alissa Walsh, Marijana Nedeljkovic Protic, Graham Heap, Fraser Cummings, Bryan F. Warren, Bruce George, N J McC Mortensen, Simon Travis

    Publicado em 2010
    Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  13. 13
    Food-related quality of life is impaired in inflammatory bowel disease and associated with reduced intake of key nutrients

    Food-related quality of life is impaired in inflammatory bowel disease and associated with reduced intake of key nutrients por Kevin Whelan, Trevor Murrells, Myfanwy Morgan, Fraser Cummings, Catherine Stansfield, Anne Todd, Shaji Sebastian, Alan Lobo, Miranda Lomer, James O. Lindsay, Wladyslawa Czuber‐Dochan

    Publicado em 2020
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  14. 14
    Subcutaneous Infliximab Monotherapy Versus Combination Therapy with Immunosuppressants in Inflammatory Bowel Disease: A Post Hoc Analysis of a Randomised Clinical Trial

    Subcutaneous Infliximab Monotherapy Versus Combination Therapy with Immunosuppressants in Inflammatory Bowel Disease: A Post Hoc Analysis of a Randomised Clinical Trial por Geert D’Haens, Walter Reinisch, Stefan Schreiber, Fraser Cummings, Peter M. Irving, Byong Duk Ye, Dong‐Hyeon Kim, Sang-Wook Yoon, Shomron Ben–Horin

    Publicado em 2023
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  15. 15
    Biosimilar Infliximab in Inflammatory Bowel Disease: Outcomes of a Managed Switching Programme

    Biosimilar Infliximab in Inflammatory Bowel Disease: Outcomes of a Managed Switching Programme por Violeta Razanskaite, Marion Bettey, Louise Downey, Julia L. Wright, J Callaghan, Miles Rush, Simon Whiteoak, Sarah Ker, Kim Perry, Caron Underhill, Efrem Eren, Iftikar Ahmed, Fraser Cummings

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  16. 16
    P245 Biologics Sequencing in Clinical Units (BISCUITS): Comparing outcomes in Crohn’s disease patients on second-line biologics

    P245 Biologics Sequencing in Clinical Units (BISCUITS): Comparing outcomes in Crohn’s disease patients on second-line biologics por Giulia Bartalucci, Frederick R. Taylor, C. Gleave, Liz Dobson, Keith Bodger, Susanna Dodd, Stuart Bloom, Alun Passey, R Nissinen, Daniel Wirth, Darian Andreas, J Lee, Fraser Cummings

    Publicado em 2024
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  17. 17
    Confirmation of the role of ATG16l1 as a Crohnʼs disease susceptibility gene

    Confirmation of the role of ATG16l1 as a Crohnʼs disease susceptibility gene por Fraser Cummings, Rachel Cooney, Saad Pathan, Carl A. Anderson, Jeffrey C. Barrett, John Beckly, Alessandra Geremia, Laura Hancock, Changcun Guo, Tariq Ahmad, Lon R. Cardon, Derek P. Jewell

    Publicado em 2007
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  18. 18
    Consensus recommendations for patient-centered therapy in mild-to-moderate ulcerative colitis: the i Support Therapy–Access to Rapid Treatment (iSTART) approach

    Consensus recommendations for patient-centered therapy in mild-to-moderate ulcerative colitis: the i Support Therapy–Access to Rapid Treatment (iSTART) approach por Silvio Danese, Rupa Banerjee, Fraser Cummings, Iris Dotan, Paulo Gustavo Kotze, Rupert W. Leong, Kristine Paridaens, Laurent Peyrin‐Biroulet, Glyn Scott, Gert Van Assche, Jan Wehkamp, Jesús K. Yamamoto‐Furusho

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  19. 19
    IL23R Variation Determines Susceptibility But Not Disease Phenotype in Inflammatory Bowel Disease

    IL23R Variation Determines Susceptibility But Not Disease Phenotype in Inflammatory Bowel Disease por Mark Tremelling, Fraser Cummings, Sheila Fisher, John Mansfield, Rhian Gwilliam, Andrew Keniry, Elaine R. Nimmo, Hazel E. Drummond, Clive M. Onnie, Natalie J. Prescott, Jeremy Sanderson, Francesca Bredin, Carlo Berzuini, Alastair Forbes, Cathryn M. Lewis, Lon R. Cardon, Panos Deloukas, Derek P. Jewell, Christopher G. Mathew, Miles Parkes, Jack Satsangi

    Publicado em 2007
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  20. 20
    Real-world assessment of effectiveness and safety of filgotinib in 286 patients with ulcerative colitis in 9 UK centres

    Real-world assessment of effectiveness and safety of filgotinib in 286 patients with ulcerative colitis in 9 UK centres por David Young, Sohail Rahmany, Deborah R. Taylor, E. A. Davis, Michael Colwill, Sonia Kalyanji Mehta, Roisin Campbell, Karl Hazel, Karishma Sethi-Arora, Susan Ritchie, Ashley Heinson, Helen Moyses, Keith Bodger, Emma Johnston, Lucy Hicks, Anjan Dhar, Jimmy K. Limdi, Rachel Cooney, John Paul Seenan, Kamal Patel, Alissa Walsh, Fraser Cummings

    Publicado em 2025
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:

Ferramentas de busca: